We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Mutation spectrum and enzyme profiling of G6PD deficiency in neonates of north India: a prospective study.
- Authors
Bhattacharyya, Upasana; Deswal, Preeti; Polipalli, Sunil Kumar; Sharma, Diksha; Kaur, Manpreet; Kabra, Madhulika; Gupta, Neerja; Agarwal, Ramesh; Deorari, A. K.; Paul, V. K.; Roy, Shevendru; Sanjeev, R. K.; Tomar, R. S.; Bhasin, J. S.; Tyagi, Amit; Sharma, V. K.; Gulati, Anil; Yadav, Rajesh; Faridi, M. M. A.; Batra, Prerna
- Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked disorder with well-established clinical and allelic heterogeneity and ethnic disparity. With ~390,000 annual births with G6PD deficiency in India, it emerges as the most predictable and preventable inborn metabolic error. Disease prevalence and mutation spectrum have been reasonably reported from central, western and southern parts of India and are mostly retrospective studies. Although prevalence data from north India is available, there is paucity of data on the mutation spectrum and genotype–phenotype correlation (G×P). Thus, we aimed at establishing the clinical and mutation profiles for G6PD, as a part of a large prospective newborn screening study conducted between 2014 and 2016 across hospitals in Delhi, India. G6PD activity levels were measured at 24–48 h of life for ~200,000 neonates using Victor 2D and/or Genomic Screening Processor followed by confirmatory spectrophotometric analysis using RBC lysates of the respective neonates based on clinical symptoms. A subset of 570 enzyme deficient neonates were screened for mutations by polymerase chain reaction-restriction fragment length polymorphism and/or Sanger sequencing. Mediterranean was the most common mutation (n=318; 55.8%) with the lowest enzyme activity and most severe phenotype, followed by G6PD Orissa (n=187;32.8%); Kerala-Kalyan (n=25); Jammu (n=24); Mahidol (n=14); Chattam (n=1) and Nilgiri/Coimbra (n=1). Of the 163 intramural neonates followed up, 68 developed clinical jaundice. However, no correlation was observed between jaundice and enzyme level. Notable outcome of this first ever prospective screening approach for G6PD deficiency in neonates may help in prediction of disease severity and appropriate timely management.
- Publication
Journal of Genetics, 2023, Vol 102, Issue 2, p1
- ISSN
0022-1333
- Publication type
Article
- DOI
10.1007/s12041-023-01437-7